NNC 687

Known as: NNC 01-0687, NNC-01-0687, NNC-687 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2002
01219922002

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
This paper details the first study of the effects of dopamine D1 receptor antagonism on the regulation of human sleep EEG… (More)
Is this relevant?
Review
2002
Review
2002
  • Derek Eder
  • Current opinion in investigational drugs
  • 2002
CEE-03-310 is a selective dopamine D1-like receptor antagonist with no appreciable binding affinity for other receptors. Although… (More)
Is this relevant?
Review
1999
Review
1999
A large number of ligand binding studies have shown that clozapine has a number of receptor affinities, including those of the… (More)
Is this relevant?
1998
1998
The article by Ninan and Kulkarni (1998) adds to the growing evidence that dopamine agonist-like properties of clozapine may… (More)
  • figure 1
  • table 1
Is this relevant?
1992
1992
The neurochemical properties of three novel benzazepine derivatives NNC-112, NNC-687 and NNC-756 were assessed. These compounds… (More)
Is this relevant?
1992
1992
The ability of dopamine D2, mixed D1/D2 and selective D1 receptor antagonists, including NNC-112, NNC-687, NNC-756, to inhibit… (More)
Is this relevant?